Zinilisib
Zinilisib (Zinilisibum) is a PI3K inhibitor. Zinilisib potently inhibits the phosphorylation of AKT in cells expressing mutant PI3KαH1047R and wild-type PI3Kα, with IC50 values of 1-500 nM and 2-15 μM, respectively. Zinilisib can be used in breast cancer-related research.
For research use only. We do not sell to patients.
- CAS No.: 3031974-57-6
- Formula: C26H29F3N4O3
- Molecular Weight:502.53
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
Zinilisib (Example 8) potently inhibits the proliferation of T47D cells expressing mutant PI3KαH1047R, with a mean EC50 ranging from 1 nM to 500 nM; it also inhibits the proliferation of SKBR3 cells expressing wild-type PI3Kα, with a mean EC50 ranging from 2 μM to 15 μM[2].
Zinilisib (6 h) potently inhibits AKT phosphorylation in T47D cells expressing mutant PI3KαH1047R, with a mean IC50 ranging from 1 nM to 500 nM; it also inhibits AKT phosphorylation in SKBR3 cells expressing wild-type PI3Kα, with a mean IC50 ranging from 2 μM to 15 μM[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:T47D cells expressing mutant PI3Kα (H1047R), SKBR3 cells expressing wild-type PI3Kα
-
Concentration:10-point dilution series
-
Incubation Time:72 h
-
Result:Inhibited proliferation of T47D cells with an average EC50 in the range of 1 nM to 500 nM.
Inhibited proliferation of SKBR3 cells with an average EC50 in the range of 2 μM to 15 μM.
Chemical Information
-
CAS No. 3031974-57-6
-
Molecular Weight 502.53
-
Formula C26H29F3N4O3
-
SMILES
OC(C(C=CC=C1)=C1N[C@@H](C2=C3C(C(N(C(N4CCN(CC4)CC(F)(F)F)=C3)C)=O)=CC(C)=C2)C)=O
-
Synonyms
zinilisibum
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)